PEG paclitaxel

Drug Profile

PEG paclitaxel

Alternative Names: Paclitaxel macrogol; Polyethylene glycol paclitaxel

Latest Information Update: 29 Apr 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Enzon Pharmaceuticals
  • Class Antineoplastics; Paclitaxels
  • Mechanism of Action Mitosis inhibitors; Tubulin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Cancer

Most Recent Events

  • 14 Jan 2003 Suspended - Phase-I for Cancer in USA (unspecified route)
  • 07 Jun 2001 Phase-I clinical trials for Cancer in USA (Unknown route)
  • 09 Jan 2001 IND submitted to the FDA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top